• 1
    Gross CP, Anderson GF, Powe NR. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med. 1999; 340: 18811887.
  • 2
    Brown ML, Fintor L. The economic burden of cancer. In: GreenwaldP, KramerBS, WeedDL, editors. Cancer prevention and control. New York: Marcel Dekker, 1995: 6981.
  • 3
    Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health. 2001; 22: 91113.
  • 4
    Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002; 40(8 Suppl ): IV-104IV-117.
  • 5
    Antos JR, Goyburu A. Comparing Medicare and private health insurance spending. Washington, DC: Heritage Foundation, 2003.
  • 6
    Moon M. Beneath the averages: an analysis of Medicare and private expenditures. Washington, DC: Kaiser Family Foundation, 1999.
  • 7
    Medicare Payment Advisory Commission. Assessing payment adequacy and updating payments in fee-for-service Medicare. In: Medicare Payment Advisory Commission. Report to the Congress: Medicare payment policy (March 2003). Washington, DC: Medicare Payment Advisory Commission, 2003: 2752.
  • 8
    Thorpe K, Howard DH. Health insurance and spending among cancer patients. Health Aff (Millwood). 2003; W3: 189198.
  • 9
    Marquis MS, Long SH. Public insurance expansions and crowd out of private coverage. Med Care. 2003; 41: 344356.
  • 10
    Cohen JW, Monheit AC, Beauregard KM, et al. The Medical Expenditure Panel Survey: a national health information resource. Inquiry. 1996; 33: 373389.
  • 11
    Cohen SB. Sample design of the 1997 Medical Expenditure Panel Survey household component. Methodology Report No. 11. Rockville, MD: Agency for Healthcare Research and Quality, 2000.
  • 12
    Selden TM, Levit KR, Cohen JW, et al. Reconciling medical expenditure estimates from the MEPS and the NHA, 1996. Health Care Finance Rev. 2001; 23: 161177.
  • 13
    Levit K, Smith C, Cowan C, Lazenby H, Sensenig A, Catlin A. Trends in U.S. health care spending, 2001. Health Aff (Millwood). 2003; 22: 154164.
  • 14
    Miller VP, Ernst C, Collen F. Smoking-attributable medical care costs in the USA. Soc Sci Med. 1999; 48: 375391.
  • 15
    Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983; 78: 605610.
  • 16
    Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998; 17: 283296.
  • 17
    Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ. 1998; 17: 247282.
  • 18
    Statistical Research and Applications Branch, National Cancer Institute. Cancer Prevalence Database [data base online]. Available from URL: [accessed February 27, 2003].